565 Relationships between tezacaftor/ivacaftor administration, gut microbiota composition, and intestinal function in cystic fibrosis

Autor: Marsh, R., Hanson, L., Ng, C., Mitchell-Whyte, M., Dellschaft, N., Hoad, C., Marciani, L., Gowland, P., Spiller, R., Major, G., Smyth, A., Rivett, D., van der Gast, C.
Zdroj: In Journal of Cystic Fibrosis October 2022 21 Supplement 2:S314-S315
Databáze: ScienceDirect